Replimune (REPL) Property, Plant & Equipment (Net) (2018 - 2026)

Replimune (REPL) Property, Plant & Equipment (Net) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 642,333.36
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.32 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.64 Bn
4 NuCana 279.75 Bn 279.75 Bn - 875,249.36
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 31.48 Mn
10 Replimune 970.73 Mn 970.73 Mn - 12.97 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.97 Mn
Mar 31, 2026 12.97 Mn
Dec 31, 2025 13.85 Mn
Dec 31, 2025 13.85 Mn
Sep 30, 2025 14.71 Mn
Sep 30, 2025 14.71 Mn
Jun 30, 2025 14.68 Mn
Jun 30, 2025 14.68 Mn
Mar 31, 2025 13.74 Mn
Mar 31, 2025 13.74 Mn
Dec 31, 2024 13.62 Mn
Dec 31, 2024 13.62 Mn
Sep 30, 2024 12.59 Mn
Sep 30, 2024 12.59 Mn
Jun 30, 2024 11.40 Mn
Jun 30, 2024 11.40 Mn
Mar 31, 2024 10.48 Mn
Mar 31, 2024 10.48 Mn
Dec 31, 2023 9.47 Mn
Dec 31, 2023 9.47 Mn